Norwalk drops out of CMS Administrator succession

13 May 2007

Leslie Norwalk, the Acting Administrator of the US Centers for Medicare and Medicaid Services (CMS), told President George W Bush that she did not want a permanent appointment when she took over at the agency, following the resignation of Mark McClellan (Marketletters passim). The news came as Republican President Bush nominated a 24-year veteran at the Department of Health and Human Services, Kerry Weems, for confirmation by the Democrat-controlled Senate.

In a memorandum sent to CMS staff, Ms Norwalk wrote: "I believe the next Administrator must be committed to stay for the remainder of the administration. It was not easy, but I decided early in the search process that I could not commit to staying for another two years." She added that she had promised to remain in the Administrator position until the Senate confirms a permanent choice.

President Bush also announced the appointment of Tevi Troy, a White House staffer, to replace the outspoken former HHS Deputy Secretary, Alex Azar (Marketletters passim), who resigned shortly after the Democrats took control of Congress.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight